当前位置：药药网 / 医药文献 /制药提价与抑制仿制药方式(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于1,小于132)：
制药提价与抑制仿制药方式 472条(本栏目收费,不能显示细节,电话13136136841)
Actelion (drug company), 82,83
82 83
active ingredient defined, 27
27
Actos (antidiabetic drug, Takeda), 58,59
58 59
Alice line of cases, 84
84
See also FTC v. Actavis as curb of citizen petitions as delay tactic, 133,35
133 35
In re Cipro (California Supreme Court), 46,47
46 47
In re Loestrin, 61, 64
61 64
Noerr- Pennington cases, 99,100, 134
99 100 134
rule of reason test in, 45,46
45 46
Teva over provigil (narcolepsy drug), 47,48
47 48
Approved Drug Products with Therapeutic
Equivalence Evaluations. See Orange Book
Argatroban (drug to prevent blood clotting), 117
117
Asacol (chronic ulcerative colitis drug, Warner Chilcott), 74,76
74 76
product hopping of Prilosec to Nexium by, 71,74
71 74
authorized generics, 59,60
59 60
automatic substitution laws, 20
20
Best Pharmaceuticals for Children Act(2002), 110
110
bioequivalency of generics, 22
22
concern over drop in at J.P. Morgan Healthcare Conference (2016), 1,2
1 2